Companies / Rare Genomics Institute
Rare Genomics Institute
United States
Rare Genomics Institute is a non-profit that bridges the healthcare gap for undiagnosed rare disease patients through international patient advocacy, clinical genomic sequencing, and partnerships with researchers and biomedical technology companies.
Rare Genomics Institute, based in United States, has 1 investor on file, among them Praxis. Its site was last checked 18 Nov 2026: site answers.
Investors
1 investor on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Accelerator |
More from Praxis
326 companies on its checked portfolioIts portfolio leans to Education (22%), Consumer (17%), Healthcare & Biotech (17%).
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Rare Genomics Institute and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Praxis adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/raregenomics.org/investors
# also
GET /v1/companies/raregenomics.org
GET /v1/companies/raregenomics.org/news